The Board of International Biotechnology Trust and SV Health Investors announce that Carl Harald Janson has decided to step back from his role as Lead Investment Manager after seven successful years at the Company's helm. Lead responsibility for portfolio management will transition to Ailsa Craig and Marek Poszepczynski and the Board has approved them as joint Lead Investment Managers.